NATASHA BELL: Open Payments
NPI 1629667670 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 59 payments from 15 companies in 2025. Trend: 2023 $621 · 2024 $676 · 2025 $1,442
Food & beverage: $1,333Education: $109
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $306 |
| ABBVIE INC. | 16 | $301 |
| Janssen Biotech, Inc. | 5 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $143 |
| Madrigal Pharmaceuticals | 6 | $139 |
| QOL Medical, LLC | 3 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
| Fujifilm Healthcare Americas Corporation | 1 | $32 |
| Novo Nordisk Inc | 1 | $30 |
Products named: DUPIXENT, TREMFYA, XIFAXAN, REZDIFFRA, RINVOQ, Sucraid, ENTYVIO, SKYRIZI.
Industry payments across FL — which companies pay providers there.
